Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies
about
sameAs
Drug-loaded erythrocytes: on the road toward marketing approvalMacrophage depletion by free bisphosphonates and zoledronate-loaded red blood cellsCo-opting biology to deliver drugsAdministration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapyRecent advances in delivery systems for anti-HIV1 therapy.Biological gene delivery vehicles: beyond viral vectors.Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.Drug delivery by red blood cells: vascular carriers designed by mother nature.Targeted therapeutics and nanodevices for vascular drug delivery: quo vadis?Cell-based drug-delivery platforms.Approaches to erythrocyte-mediated drug delivery.New drug combinations for the treatment of murine AIDS and macrophage protection.Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphono methoxypropyl)adenine.Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain.Macrophage depletion induced by clodronate-loaded erythrocytes.Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir.Surface-modified loaded human red blood cells for targeting and delivery of drugs.Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.
P2860
Q26765322-FE5C3DAB-94FA-46D6-8A66-F6634CCB6250Q28540086-7626D17F-094E-431F-851D-169E0F9D2F0AQ34424045-CCAD5354-A40F-4D67-9B06-460F600072E4Q35139258-D682EF17-F345-4207-B37E-8D9E9A974AC4Q36761854-E5A4BD1A-4CAD-4A21-A4C9-8F1F19BC1F71Q37412239-5463C636-D66F-4A09-A7FD-4C75D42FE754Q37638602-CB96EC4B-2EE9-49AD-9112-C5B59C6681C1Q37700751-919FE945-9D1D-4EAD-8EC7-E1BF7A6DAC6CQ37896555-8717858F-0832-4DE3-9E33-162B4EDC40DDQ38029631-AEA7421D-02DD-495D-B7DD-774CECDE106BQ38189095-07FDA99F-A57B-4A61-8B59-C7CD22974307Q43551317-60CC3754-C399-4482-9454-B74CB5CC01F9Q44575608-EDE71A9B-11FF-4CD4-BE16-D805699605DAQ44612406-973DB7AD-7F81-4EFA-837A-6E8FAC3A7B36Q46432782-E41AC13D-24C7-473F-BB38-A2D9C20EF4D0Q46866833-DC332B5E-19AF-4A6F-B435-CE5320B1A581Q50523900-286FE908-58D6-43B2-8BAA-D8F8C56585FFQ51059588-03119AFA-4509-43DA-B89A-A959262672CA
P2860
Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@ast
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@en
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@nl
type
label
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@ast
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@en
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@nl
prefLabel
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@ast
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@en
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@nl
P2093
P2860
P921
P356
P1476
Targeting antiretroviral nucle ...... : in vitro and in vivo studies
@en
P2093
G F Schiavano
G Piedimonte
M Montroni
P2860
P304
P356
10.1073/PNAS.89.14.6477
P407
P577
1992-07-15T00:00:00Z